相关期刊:《世界最新医学信息文摘》《Frontiers of Medicine》《Frontiers of Chemical Science and Engineering》《Journal of Wuhan University of Technology(Materials Science)》更多>>
Capital's Funds for Health Improvement and Research (No.2018-4-4089);the Key Program of the National Natural Science Foundation of China (No.81530046);Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No.81621001);the Science and Technology Project of Guangdong Province of China (No.2016B030230003);the National Science and Technology Support Program (No.2014BAI09B13);the Project of Health Collaborative Innovation of Guangzhou city (No.201704020214).
The efficacy of minimal residual disease (MRD)-directed immunotherapy,including interferon-α (IFN-α) treatment and chemotherapy plus granulocyte colony-stimulating factor-primed donor leukocyte infusion (chemo-DLI),...
the National Natural Science Foundation of China (No.81400145);the Beijing Talents Fund (No.2015000021223ZK39);the Key Program of the National Natural Science Foundation of China (No.81530046);Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No.81621001);the Science and Technology Project of Guangdong Province of China (No.2016B030230003).
The efficacy of salvage interferon-α(IFN-α) treatment was investigated in patients with unsatisfactory response to minimal residual disease (MRD)-directed donor lymphocyte infusion (DLI)(n=24). Patients who did not ...